16 Oct 25
Welcome to tranScrip’s monthly newsletter where we share with you the latest news and views from across the organisation. This edition includes:
A message from our Chief Executive Officer
Dear Readers,
As we transition into the final quarter of the year, it’s clearer than ever that forward-thinking strategy and expert collaboration are what differentiate success in today’s biopharma environment. In this edition, you’ll hear how our team continues to deliver on our mission to enable our client’s to maximise the value of their products for the benefit of patients worldwide – from decoding regulatory incentives in the EU to launching new ways to share strategic insights through “tranScrip Talks”.
We’re seeing significant global shifts – from growing regulatory complexity to the increasing pressure to deliver patient impact faster. Our clients value the breadth of expertise we offer across the product lifecycle – from translation to prescription – with access to seasoned physicians and scientists, alongside regulatory, clinical, and commercial experts, all working together to deliver integrated, high-impact solutions. At tranScrip, we’re proud to stand beside our clients and partners to help navigate this evolving landscape with confidence.
Stay connected – and as always, we welcome your thoughts and feedback.
Warm regards,
Mark Corbett
Chief Executive Officer
“tranScrip Talks” Podcast – Episode #1 NOW LIVE
The wait is over! The first episode of tranScrip Talks has officially launched.
In this episode, tranScrip’s CMO, Dr Rienk Pypstra joins David Findlay, CEO of Rostra Therapeutics, to lay out the essential foundations for biotech success.
They explore why it’s vital to:
Whether you’re founding your first biotech or steering a late-stage programme, this episode is packed with strategic and practical insights – from TRANslation to preSCRIPtion.
Press play now: tranScrip | Spotify | Apple Podcasts | YouTube | Amazon Music
Don’t miss future episodes – follow us on LinkedIn to stay updated.
SME Status & Orphan Drug Designation – Are You Missing Out?
Did you know you don’t need to be based in the EU to benefit from SME Status or Orphan Drug Designation?
Too many companies miss out on these incentives, either because they don’t realise they’re eligible or find the application process too complex.
The result? Lost time, higher costs, and missed opportunities to protect innovation.
At tranScrip, we help biotech and pharma companies unlock cost savings, regulatory guidance, market exclusivity and accelerated pathways – ensuring you maximise value and bring medicines to patients faster.
Discover how SME Status and ODD can transform your EU drug development strategy: How SME Status and Orphan Drug Designation Can Transform Your EU Drug Development Strategy
Key Takeaways from “A Biotech Guide to Vendor Oversight”
From budget overruns to timeline delays, the risks of inadequate vendor oversight are real.
In our latest webinar, tranScrip experts explored the real-world impact of inadequate vendor oversight – revealing how poor management can derail development programmes. Through insightful case studies, we demonstrated how proactive oversight strategies can not only rescue troubled projects but also set you up for success from the outset.
For a concise recap, we’ve compiled a summary of the key takeaways >
Couldn’t join us live? Watch on demand now: Vendor Oversight Webinar Recording
Upcoming Conferences
As summer draws to a close, we’re preparing for a packed conference season — and we’d love to see you there.
From September our team will be attending several key industry events. Here’s where you can find us:
TOPRA Careers 2025
📅 9 September
📍 London
👤 Roz Sutton
GAMRIC
📅 1–3 October
📍 London
👤 Rienk Pypstra
BIOSPAIN
📅 7–9 October
📍 Barcelona
👤 Iñigo Montes
ID Week
📅 12–22 October
📍 Atlanta
👤 Rienk Pypstra & Iñigo Montes
Let’s Connect
Planning to attend any of these events?
Whether you’re interested in discussing potential collaborations, exploring our capabilities, or simply saying hello, we’d be delighted to chat.
Get in touch to arrange a meeting with one of our experts > Contact Us
Thank you for reading this month’s edition of tranScrip’s newsletter. To learn more about how we can support your product development, connect with us.
From TRANslation to preSCRIPtion – we’re with you every step of the way.
Best regards, The tranScrip Team
Our experienced physicians and scientists, together with our regulatory, clinical and commercial experts can support you to maximise the value of your products. Whatever your project requires, we have the expertise to meet your needs.